FH
Foghorn Therapeutics Inc.
FHTX · NASDAQ
$4.67 -1.89% (-$0.09)
1M -22.60%
Market Cap $283.6M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
8 /100
Expensive P/S 7.72x
EV/FFO N/A
P/B N/A
Growth
96 /100
Growing Rev. growth 17.14%
FCF growth N/A
Book val. growth N/A
Profitability
17 /100
Weak Net margin 175.78%
Op. margin 186.38%
FCF margin 232.31%
Quality
3 /100
Poor ROA 31.75%
Asset turnover 0.18x
ROIC 44.00%
Debt
100 /100
Low Current ratio 3.36x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
31 /100
Unstable Rev. volatility 56.38%
EPS volatility 11.11%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre FHTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Adrian H. Gottschalk
Employees
106
Headquarters
Watertown
Evenimente viitoare
04 NOV.
Earnings
Upcoming earnings report